In non-pregnant individuals, a strong positive association of sodium intake with blood pressure has been established, but the relationship between sodium intake and blood pressure in human pregnancy remains obscure up to date. The aim of this prospective observational cohort study was to assess the relationship between urinary sodium excretion (as a measure for intake) and blood pressure from the early second trimester onwards throughout pregnancy. The study group consisted of 667 low-risk women with singleton pregnancies, of whom 350 were nulliparous and 317 parous. Blood pressure was measured in a standardised fashion at predetermined intervals from the first antenatal visit prior to 16 weeks gestation until delivery. Urinary sodium excretion was measured in 24-h urine collections on at least four occasions between 16 and 38 weeks gestation. Main outcome measures were the
Introduction
Hypertensive disease is one of the commonest complications of human pregnancy and a major cause of maternal and perinatal morbidity and mortality worldwide. [1] [2] [3] Hypertension in pregnancy can either be chronic hypertension antedating pregnancy, or a sign of a condition secondary and specific to pregnancy, referred to as gestational hypertension or, when proteinuria coincides with it, pre-eclampsia.
In non-pregnant individuals, a strong positive association of sodium intake with blood pressure has been established by the Intersalt study. 4 Subsequent reviews of cross population studies, within population studies and clinical trials of dietary sodium restriction all confirmed this association in non-pregnant individuals, although the size of the estimate differed. [5] [6] [7] [8] [9] From a recently published reanalysis of the Intersalt study the effect of a median sodium excretion higher than 100 mmol/day over a 30-year period appears to be a further rise of systolic pressure by 10 to 11 mm Hg and of diastolic pressure by 6 mm Hg. 10 These results lend support to rec-ommendations for reduction of high sodium intake to prevent chronic hypertension on the long term. Among the many theories launched on the yet unknown cause and pathophysiology of gestational hypertension, nutritional factors have been held responsible too. 11 Especially the sodium content of food has received much attention since the turn of the century. 12 However, the relationship between sodium intake and blood pressure in pregnancy remains obscure up to date. De Snoo, an authoritative Dutch obstetrician in the first half of the century, postulated that salt retention was a primary event, resulting in an increased sodium concentration in blood and a subsequent increase in blood pressure. 13 In his concept, oedema during pregnancy was not a physiological sign but a manifestation of excessive sodium and subsequent water retention as a consequence of a diminished sodium tolerance due to an increased affinity of the tissues. De Snoo considered the blood pressure rise in late pregnancy as a compensatory mechanism which, by increasing natriuresis, was the woman's effort to lower the sodium content of the blood. Since it had been shown that excess sodium is quickly excreted in the urine after delivery, 14 De Snoo concluded that the primary sodium retention and the subsequent rise of blood pressure in late pregnancy was not due to diminished kidney function but rather to a relatively high sodium intake. From 1913 onwards De Snoo advo-cated to prescribe a low-sodium diet to pregnant women with oedema, in order to prevent the occurrence of eclampsia. 13, 15 However, in none of his numerous papers De Snoo claimed that sodium restriction was effective to lower blood pressure. 16 Nevertheless, Dutch midwives and obstetricians continue to prescribe low sodium diets to pregnant women with high or increasing blood pressure up to date.
No evidence has ever been produced that sodium intake and blood pressure are interrelated during pregnancy. 16 Former studies on this relationship were either too small or subject to methodological shortcomings, or were limited to late pregnancy. We studied the association of changes in urinary sodium excretion with changes of blood pressure throughout pregnancy in a large cohort of low-risk women.
Subjects and methods
A prospective cohort study was designed to assess the interrelationship of dietary sodium intake with blood pressure in pregnancy. Sodium intake was estimated by measurement of 24-h urinary sodium excretion. To ensure a homogeneous low-risk study population, collaboration was obtained from 15 midwives' practices in the area of the Maria Ziekenhuis, a general hospital in Tilburg, The Netherlands. The study was approved by the hospital's researchethics committee.
Subjects
All nulliparous and parous women with singleton pregnancies booking for antenatal care in the participating midwives' practices before the 16th week of gestation between 1 June 1990 and 31 March 1991 were eligible for entry in the study. Informed consent was obtained before enrolment. Gestational age was determined from the best estimate according to menstrual history or ultrasound measurement early in pregnancy.
Blood pressure measurements
Since conventional mercury sphygmomanometry is subject to observer bias and error, 17 blood pressure measurement was standardised by using an automated device, the BOSO Pa (Bosch & Sohn, Jungingen, Germany). This device operates on oscillometry. We validated it for use in pregnancy. 18 Blood pressure was measured once with the woman in the sitting position, and with the cuff at heart level. These standardised blood pressure measurements were taken during the antenatal visits at booking and at 16, 20, 24, 28, 32, 36, 37, 38, 39 and 40 weeks gestation.
Assessment of urinary sodium excretion
All participating women were requested to collect a 24-h urine sample at 16, 20, 24, 28, 32, 36 and 38 weeks gestation. To avoid collection errors, the women received detailed written instructions beforehand on every occasion. Urine was collected in 2-litre plastic containers without a preservative, and analysed in the Central Clinical Laboratory in Tilburg, The Netherlands. Urinary sodium was measured by ion-selective electrode indirect potentiometry, 19 and creatinine by a method based on the alkaline picrate Jaffé reaction (Technicon RA-XT, Bayer Diagnostics, Mijdrecht, The Netherlands). 20 The results of the urine analyses remained unknown to the participating midwives and pregnant women.
Pregnancy outcome
Gestational hypertension was defined as a diastolic pressure of 90 mm Hg or more at two consecutive occasions at least 4 h apart, in the second half: of pregnancy of a previously normotensive woman. 21 Pre-eclampsia was defined as gestational hypertension with proteinuria of 300 mg/24 h or more at a single occasion. 21 Preterm delivery was defined as a spontaneous or induced delivery prior to 259 days gestation. For each baby its position vis-a-vis the 2.3rd and the 10th birth weight centile for the Dutch population was determined.
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Data analysis
For each individual woman, the mean and standard deviation (s.d.) of urinary creatinine were calculated from her own series of urine collections. From these intra-individual means and intra-individual standard deviations, one mean and one average s.d. were calculated for the whole cohort. Urine collections with a volume less than 400 ml or a creatinine content below the group's mean minus 3 standard deviations (mean − 3s.d.) were considered to be incomplete 24-h collections and thus omitted from analysis. Also, urine collections with a volume exceeding 3000 ml or a creatinine content by more than the group's mean + 3s.d. were omitted as being overcomplete. Subsequently, the intra-individual coefficient of variation (CV) of creatinine was calculated for each individual woman, as:
In non-pregnant individuals the CV of creatinine is less than 25%, 23 and on average about 10%, 24 when calculated for a series of only complete 24-h urine collections. Although the CV of creatinine has not been validated for pregnancy, there is no better arbiter of completeness of 24-h urine collections in pregnant women at present. Thus, the final analysis only included those women who had collected a series of at least four 24-h urine samples with a CV of creatinine less than 25%.
For these women the changes in urine sodium excretion were calculated from 16 to 20 weeks gestation (defined as sodium excretion at 16 weeks minus sodium excretion at 20 weeks), 20 to 24 weeks (20 minus 24 weeks), 24 to 28 weeks (24 minus 28 weeks), 28 to 32 weeks (28 minus 32 weeks), 32 to 36 weeks (32 minus 36 weeks) and 36 to 38 weeks (36 minus 38 weeks). For the same gestational intervals, changes in systolic and dia-161 stolic blood pressure were calculated. Main outcome measures were the coefficients of correlation of changes in sodium excretion with changes in blood pressure. 25 These correlation coefficients were calculated for the whole cohort, as well as for nulliparous and parous women separately, and for each of the six gestational intervals. Additionally, the association between changes in sodium excretion and in blood pressure was visualised in scatterplots. Nulliparous and parous women were compared by means of the unpaired t-test for continuous variables and by means of contingency-table chisquare analysis for categorical variables. Two-sided P values of less than 0.05 were considered to indicate statistical significance. Women with and without gestational hypertension were compared by means of the unpaired t-test for the serial measurements of blood pressure and sodium excretion. The level of significance per comparison was taken to be 0.10 : k (k = number of comparisons). Due to the interdependency of the values at the subsequent time points in pregnancy, the overall type I error is probably nearer to 5% than to 10%. Thus, for both blood pressure (eight comparisons between women with and without gestational hypertension) and sodium excretion (seven comparisons), two-sided P values of less than 0.01 were considered to indicate statistical significance. Creatinine excretion at 20, 24, 28, 32, 36 and 38 weeks was compared to creatinine excretion at 16 weeks by unpaired t-tests. Twosided P values of less than 0.01 were considered to indicate statistical significance.
Results
Of 1835 women eligible for entry in the study, 877 (47.8%) were enrolled by the participating midwives. The other 958 women were not recruited or refused to participate for various reasons, the most predominant one being the burden of repeated 24-h urine collections. Data of these women are lacking. Of the 877 women enrolled, seven appeared to have a twin pregnancy and 13 other women experienced spontaneous abortion soon after enrolment. Two women were lost to follow-up during pregnancy. From the remaining 855 women 5236 24-h urine collections were obtained (on average 6.1 collections per woman). One hundred and forty-eight urine collections (2.8%) were omitted as incomplete and 160 (3.1%) as overcomplete. Ninety-one of the 855 (10.6%) women were excluded from analysis because less than four complete 24-h urine collections were obtained from them. Another 97 (11.4%) women had intra-individual variation coefficients of urinary creatinine of 25% or more, and thus were also excluded. A cohort of 667 women with singleton pregnancies, of whom 350 were nulliparous and 317 parous, and who collected 4360 24-h urines (on average 6.5 per woman), remained for final analysis. All women were normotensive (diastolic pressure less than 90 mm Hg) in the first half of pregnancy. Table 1 presents the baseline and outcome characteristics of the study cohort. Maternal death and eclampsia did not occur. There were two perinatal losses, both caused by placental abruption at 32 and 40 weeks gestation respectively. As expected, mean birthweight was significantly higher for parous women compared to nulliparous women, but the proportions of small-for-gestational age infants (birthweight below the 10th or 2.3rd centile) were similar. Gestational hypertension and preterm delivery affected significantly more nulliparae than parae. Only three women, one nulliparous and two parous, developed pre-eclampsia. Figure 1 shows mean blood pressure during pregnancy, separately plotted for women who remained normotensive and those who developed gestational hypertension or pre-eclampsia. Women eventually developing gestational hypertension or pre-eclampsia had significantly higher blood pressure from the first antenatal visit onwards throughout pregnancy, except for the systolic pressure of nulliparae at 12 weeks gestation. Figure 2 shows the scatter of individual urinary sodium excretion in the cohort at 20, 28 and 36 weeks gestation. For 16, 24, 32 and 38 weeks gestation, a similar scatter was observed. Figure 3 represents mean urinary sodium excretion during pregnancy, again separately plotted for women who remained normotensive and those who developed gestational hypertension or preeclampsia. At 32 and 38 weeks gestation, nulliparous women developing gestational hypertension or pre-eclampsia had a significantly lower sodium excretion compared to their normotensive counterparts. For parae differences between normotensive and hypertensive women were never significant. Sodium excretion was also analysed by urinary sodium:creatinine ratios, but this did not yield different results (data not shown). Table 2 depicts the mean urinary creatinine excretion for each of the gestational ages, separately for normotensive women and women who developed gestational hypertension or pre-eclampsia. Creatinine excretion slightly increased with advancing pregnancy, but only in normotensive nulliparae the difference between 38 and 16 weeks reached statistical significance. Differences between nulliparae and parae, and between women remaining normotensive and those who developed gestational hypertension or pre-eclampsia were not significant. Table 3 summarises the correlation of changes in urinary sodium excretion with changes of blood pressure during pregnancy, for nulliparous, parous and all women. No significant correlations were found for any of the studied gestational intervals, regardless whether the systolic or the diastolic pressure change was considered. Correlation coefficients never exceeded 0.13. The absence of a relationship between changes in urinary sodium excretion and diastolic blood pressure changes is further illustrated by Figure 4 . This figure shows scatter plots of diastolic blood pressure changes against changes in urinary sodium excretion observed in nulliparous women, in the gestational intervals from 20 to 24 weeks, 28 to 32 weeks and 32 to 36 weeks. Plots for other gestational intervals and plots for parous women were similar. 
Discussion
To our knowledge, this is the first study attempting to assess the relationship between sodium excretion and blood pressure prospectively from the early second trimester onwards throughout human pregnancy. No correlation was found between changes in urinary sodium excretion and blood pressure changes over 4-weekly intervals between 16 and 38 weeks gestation (Table 3 , Figure 4 ). Changes in urinary sodium output varied from decreases by 100 mmol/24 h to increases by 140 mmol/24 h ( Figure 4 ). This wide range probably reflects large changes in sodium intake, partially resulting from dietary sodium restriction, which is still frequently advised by midwives in The Netherlands. However, sample errors cannot be excluded, since as many as nine 24-h urine collections would be needed to estimate an individual's habitual sodium intake reliably. 23 Obviously, this is not feasible in epidemiological studies.
The study most often referred to in the debate of sodium restriction in pregnancy is that by Robinson, conducted in the 1950s. 26 She alternately instructed 2077 women either to take more salt in their diet or to reduce the daily dietary salt intake. Surprisingly, the incidence of 'toxemia' was highest in the low salt group. However, Robinson's study has received severe critiques for two major methodological shortcomings: no attempt was made to assess compliance to the prescribed diets, and 'toxemia' was also diagnosed in women with oedema and proteinuria without hypertension. McEniery and colleagues studied the effects of short-term manipulations of dietary sodium on blood pressure in pregnancy. 27 In their small study, 22 normal pregnant women, of whom eight were primigravid, were recruited at approximately 18 weeks gestation and allocated to a randomly selected series of three diets, each for 7-10 days: a low sodium (10 mmol per day), a high sodium (300 mmol per day) and the womens' regular diet with ad libitum sodium intake. These short-term dietary manipulations produced no changes in blood pressure or heart rate. Plasma volume and plasma renin activity changed with altered sodium intake, but these changes did not correlate with changes in blood pressure between low and high sodium intake. In a former prospective randomised study in healthy nulliparous women we found no significant influence on blood pressure of chronic dietary sodium restriction started in the early second trimester. 28 Knuist and co-workers recently published the results of a trial of sodium restriction in late pregnancy in nulliparous women. 29 Two hundred and thirty-three women who were normotensive in the first half of pregnancy were randomised to either a low sodium or an ad libitum diet after diastolic blood pressure had risen to or above a threshold value of 85 mm Hg in the second half. The diets were not prescribed before 28 weeks of gestation in the majority (80%) of the women and even after 36 weeks in half of them. No difference was observed in the change in diastolic blood pressure between the low sodium group and the controls. Our present findings confirm that a direct relationship between changes in sodium intake and blood pressure is absent throughout pregnancy.
Women destined to develop gestational hypertension showed significantly higher blood pressure from the first antenatal visit onwards throughout pregnancy, compared to women who remained normotensive. This was reported before more than a decade ago from a study in 983 women. 30 The definition used for gestational hypertension, based on blood pressure in excess of an absolute threshold, apparently includes women with features suggestive of mild chronic hypertension, as pointed out before. 21, 31 On average, urinary sodium excretion showed some decrease in the course of pregnancy. For example, normotensive nulliparous women had a mean sodium output (s.d.) of 144.5 (45.3) mmol at 16 weeks and 114.9 (44.5) mmol at 38 weeks gestation, reflecting a decrease of about 0.2 mmol per Figure 1 Systolic (̅ and̆) and diastolic (̃and̄) blood pressure (represented as means and standard deviations) during pregnancy, plotted separately for nulliparous women who remained normotensive (upper panel, ̅ and̃, n = 310), nulliparous women who developed gestational hypertension or preeclampsia (upper panel,̆and̄, n = 40), parous women who remained normotensive (lower panel, ̅ and̃, n = 300) and parous women who developed gestational hypertension or preeclampsia (lower panel,̆and̄, n = 17). All pressure differences between women who remained normotensive and for women who eventually developed gestational hypertension or pre-eclampsia were statistically significant (unpaired t-test, two-sided P value Ͻ0.01) except for the systolic pressure of nulliparous women at 12 weeks gestation.
day. Several explanations may account for this, one being an increasing sodium retention with advancing pregnancy. Decreasing dietary sodium intake may be another contributing factor. Probably even to date, some midwives, obstetricians and pregnant women in The Netherlands uphold the decades-old tradition of advising and keeping low-sodium diets. On the other hand, there is some evidence that taste preference for and consumption of salt increases during pregnancy. 32, 33 Furthermore, one might argue that the womens' compliance to collect complete 24-h urines diminished with every next collection. Mean urine creatinine excretion, however, remained relatively constant with advancing gestation, confirming recent findings by Gallery and co-workers. 34 Prior to 32 weeks gestation, urinary sodium excretion did not differ significantly between nulli- parous women who remained normotensive and nulliparous women who eventually developed gestational hypertension. From 32 weeks onwards, sodium output was lower in nulliparae with gestational hypertension compared to normotensive women. This difference may be caused by manipulations of dietary sodium intake in hypertensive nulliparae, or by increased sodium retention. In parous women, differences between sodium excretion in hypertensive and normotensive women were never significant. Neither our findings nor data from other appropriate longitudinal studies lend support to a primary etiological role of renal sodium handling or the renin-angiotensin-aldosterone axis in the development of gestational hypertension. [35] [36] [37] MacGillivray and co-workers studied several parameters of sodium and volume homeostasis in 152 primigravi- dae with singleton pregnancies and 22 primigravidae with twin pregnancies during the 30th gestational week. 35 No significant differences were detected in plasma electrolytes concentrations, total body water or plasma volume, between women who remained normotensive throughout pregnancy and those who would eventually develop gestational hypertension or pre-eclampsia. In another longitudinal study, Gallery and co-workers found no differences in plasma volume between normotensive women and those destined to develop hypertension up to the 33rd week of pregnancy. 36 In a study by Brown and co-workers, baseline parameters of sodium excretion as well as sodium excretion rates and plasma renin activity after saline solution loading during the second trimester revealed no differences between continuously normotensive women and women who later developed pregnancyinduced hypertension. 37 So, the third-trimester decline of urinary sodium output in nulliparous women with gestational hypertension is more likely to reflect one of the sequelae of the pathophysiological circulatory changes rather than their cause. There is no doubt that established pre-eclampsia may be accompanied by avid sodium retention, which is mostly effected by a reduction of glomerular filtration rate (GFR) and filtered sodium load. 38 One may speculate that these changes in sodium and volume homeostasis are secondary to endothelial cell dysfunction, currently regarded to be the predominant pathophysiologic feature of preeclampsia. 39 This also fits the arterial underfill hypothesis by Schrier and colleagues. [40] [41] [42] They postulated that the changes of volume homeostasis and haemodynamics observed in normal pregnancy are primarily triggered by peripheral arterial vasodilation of yet unidentified cause, with a subsequent relative underfilling of the arterial circulation in early pregnancy. As a consequence, blood pressure falls, cardiac output rises due to afterload reduction, and the renin-angiotensin-aldosterone axis and vasopressin release are stimulated, finally resulting in renal sodium and water retention. A substantial increase in GFR, and thus of filtered sodium load, would be explanatory of the fact that only an amount of about 900 mmol sodium is retained in normal pregnancy, 38 in spite of a persistently elevated plasma aldosterone concentration. In preeclampsia, endothelial dysfunction may result in increased renal vasoconstriction, and subsequent diminution of GFR and of filtered sodium load, and thereby impaired escape of the sodium-retaining effects of aldosterone. 42 Both increased sodium Figure 4 Plots of diastolic blood pressure change against urinary sodium excretion change in nulliparous women during three different epochs in pregnancy.
retention and high blood pressure would thus be late sequelae of pre-eclampsia without a direct causal interrelationship. In this view, sodium restriction is unlikely to be effective to prevent or treat high blood pressure in pregnancy. Nevertheless, Jaspers and colleagues reported a decrease of angiotensin sensitivity in hospitalised pregnant women after their sodium intake had been restricted. They attributed this phenomenon to a direct effect of sodium on the vessel wall. 43 In summary, throughout pregnancy short-term changes of sodium excretion showed no correlation with changes in blood pressure. Prior to 32 weeks gestation, sodium excretion did not differ between women eventually developing gestational hypertension and those remaining normotensive. These findings do not lend support to a primary etiological role of altered renal sodium handling in gestational hypertension.
